Study title: Rapport d'etude: evaluation des concentrations bronchiques de colistine apres administration en aerosol, a la posologie de 1 MUI 2 fois par jour et de la tolerance de cette voie d'administration chez des patients atteints de mucoviscidose.
| Type of medicine: Medicines containing chemical active substances | |||||
| Therapeutic area: Digestive System Diseases | |||||
| Brands: Please see report | |||||
| MAH holders: Please see report, Please see report | |||||
| Assessment: | |||||
| Active substance: COLISTIN | |||||
| ATC code: J01XB01 | |||||
| Document link: Colistimethate sodium STUDY SAF-133.xls | |||||
| Document date: 2013-03-05 | |||||
| Study number: NL 30262 | |||||
| EudraCT number: | |||||
| Scope of study: Clinical | |||||
| Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
| - | - | - | Y | - | |